Patent 7510872 was granted and assigned to Nationwide Children's Hospital on March, 2009 by the United States Patent and Trademark Office.
The present invention relates to methods and materials for recombinant adeno-associated virus production. More particularly, the invention relates to use of recombinant adenovirus encoding adeno-associated virus protein in recombinant adeno-associated virus production methods.